March 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 4:00pm (GMT), 5:00pm (CET)

Responding to SARS-CoV-2 Variants, such as Omicron: Detection and Surveillance

Sponsored by: Thermo Fisher Scientific
Speakers

Abstract
Date:  March 17, 2022
Time: 9:00am (PDT), 12:00pm (EDT), 4:00pm (GMT), 5:00pm (CET)
 
Since the initial COVID-19 outbreak, the SARS-CoV-2 virus has mutated, resulting in a range of variants. SARS-CoV-2 variants of concern, exemplified most recently with Omicron, need to be detected early and accurately to ensure confidence in testing results and surveillance efforts.This includes an overview of the current pandemic state, the PCR-based TaqPath COVID-19 diagnostic solution assay design, the S gene target failure, and surveillance solutions in light of Omicron. We will present the current knowledge on the features of the Omicron variant and showcase different strategies that were used around the world to track its spread.
 
We will further discuss the different approaches for detection, discrimination, and identification of novel SARS-CoV-2 variants using genetic tests. The webinar will provide an overview of surveillance tools which can enable laboratories to scale up surveillance testing and efficiently utilize available resources to fight the ongoing COVID-19 pandemic. 
 
Learning Objectives
  • Overview of Omicron variant features and significance
  • Identify differing strategies for surveillance of SARS-CoV-2 variants
  • Discuss why the most recent, record-breaking surge in COVID-19 cases has increased the demand for rapid, accurate, and sensitive high-volume testing
  • Cite S gene target failure, why it occurs, and how it can lead to advantage in surveillance efforts
  • Illustrate the implications of viral mutations
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 29, 2022 9:00 AM PDT
C.E. CREDITS
MAR 29, 2022 9:00 AM PDT
Date: March 29, 2022 Time: 09:00am (PDT), 12:00pm (EDT), 17:00 (GMT) Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clin...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
Loading Comments...
Show Resources